Picture two identical dental practices on opposite ends of the same street — same collections, same operatories, same patient base. One owner takes the first DSO cold call and signs. The other runs a disciplined 90-day competitive process and walks away with hundreds of thousands more — frequently crossing a $1 million premium. Nothing about the dentistry changed. The only variable was the process. That's the counterintuitive truth at the heart of this episode, built on the 2026 research brief Winning the Bid Spread: valuation multiples have been flat (roughly 6–12x EBITDA) for two years, yet the gap between the lowest and highest offer on the same practice sits at a historic high.

We unpack why buyers will jump ~50% from their opening number when forced to compete — the "DSO squeeze" (69% of DSOs expect more acquisitions this year; 78% face a recapitalization in the next 12–36 months) colliding with the demographic wave (average retirement age 68.7, with 40%+ of dentists 55 or older in some states). Then we contrast the two buyer types head-to-head: the DSO's big headline multiple with only 60–80% cash at close and illiquid rollover equity, versus the private buyer's smaller headline but 75–85% cash, a secured seller note, and a clean exit. Finally, the engineering that happens before you go to market: normalizing EBITDA with legitimate add-backs (a 10–20% lift), pulling the scale and hygiene levers, and eliminating the suppressors that quietly tank a valuation.

In this episode:

• The "identical twins" thought experiment: a $1M+ difference created purely by process
• Why the multiple is set by the market but the check is set by the competition you run
• The bid spread: 5+ competing offers averaging ~50% above the initial offer (TUSK 2026)
• The DSO squeeze — 69% expanding acquisitions, 78% facing a recap deadline
• The silver tsunami: retirement at 68.7, 40%+ of dentists aged 55+
• DSO vs. private buyer: EBITDA multiple + rollover equity vs. TTM collections + clean cash and a seller note
• Why "cash at close" and rollover equity matter more than the headline number
• Normalizing EBITDA: owner comp, personal expenses, and one-time add-backs (a 10–20% lift)
• Value levers (scale premiums, 25–35%+ hygiene mix) and suppressors (Medicaid concentration and the Oct 1, 2026 OBBB cuts, provider concentration, short leases)
• Why due diligence is a "price reduction phase" — and how to disarm it before the LOI

One action this week: If you're 1–5 years from a transition, pull your trailing-12-month P&L and your production-by-provider report, sit down with a red pen, and calculate your true normalized EBITDA — including your legitimate add-backs and owner/operator replacement cost. That single exercise tells you which valuation tier you're actually in, long before you pick up the phone.

Learn more: Practice Orbit — practiceorbit.com

Source: Practice Orbit research brief, Winning the Bid Spread (2026).

In this episode of the Dental Boardroom Podcast, host Wes Read, CPA and financial advisor at Practice CFO, and Chris Marshall break down some of the most important warning signs dentists should watch out for when evaluating a dental practice for purchase. Drawing from real client cases and common deal-flow patterns, they discuss the financial, operational, and clinical red flags that often hide beneath the surface of seemingly attractive listings.

Listeners will learn how to interpret declining numbers, inconsistent hygiene schedules, sudden production increases, PPO manipulations, risky seller behaviors, and gaps in patient flow. By the end of the episode, you’ll understand how to look past broker language and identify the true health or weakness of a prospective practice.

If collections or production drop year-over-year even slightly it signals deeper issues.

This could mean a declining patient base, ineffective ownership, poor systems, lack of demand, or mismanagement.

• Large swings in hygiene revenue
• Inconsistent recall schedules
• Declining hygiene visits
• These typically indicate poor systems, weak re-care, or a lack of organization affecting long-term revenue.

A seller spiking numbers in the year before the sale is a common tactic.

Examples include:

• Over-treatment
• Running unnecessary procedures
• Pre-billing treatment
• A buyer should be cautious: inflated numbers ≠ sustainable revenue.

Practices sometimes:

• Drop PPOs before selling
• Switch PPO participation
• Adjust fee schedules to appear more profitable
• Understanding the insurance environment is essential to projecting true cash flow.

Pay attention if the seller:

• Wants to leave immediately
• Avoids answering questions
• Has incomplete records

Shows disorganized systems

These behaviors often align with financial or operational decline.

In this episode, Wes Read, CPA and founder of PracticeCFO dives into one of the most important financial terms in dentistry: EBITDA. Whether you're planning to sell your practice or simply want to manage it better, understanding EBITDA is essential. Wes explains what it is, how to interpret it from your P&L, and why every dental professional—owner or associate—should know the business side of dentistry.

This episode is designed to help you start thinking like a CEO of your dental practice. Because yes, it’s a practice—but it’s also a business, with payroll, debt, taxes, benefits, and financial planning responsibilities.

• EBITDA is a key financial metric every dental practice owner should understand.
• Even associates benefit from learning the business side of dentistry.
• Your dental practice operates like any other business—complete with payroll, taxes, and budgets.
• Understanding financials helps you become an effective CEO of your practice.
• Unlike large corporations, dentists provide services (not products), but the financial principles still apply.

#DentalBusiness #DentalPracticeManagement #EBITDA #DentalFinance #DentistryPodcast #DentalCEO #DentalAssociates #PracticeOwnership #DentalEntrepreneur #FinancialLiteracy #P&LExplained #BusinessOfDentistry